Tag Archives: Pennsylvania
Research!America Honors Congressmen Frank Wolf and Chaka Fattah for Advancing Medical Innovation to Save Lives and Strengthen the Economy
Reps. Wolf and Fattah to Receive the Edwin C. Whitehead Award for Medical Research Advocacy at Research!America’s Advocacy Awards Dinner on March 12
ALEXANDRIA, Va.–February 12, 2014-Reps. Frank Wolf (R-VA) and Chaka Fattah (D-PA) will receive the Edwin C. Whitehead Award for Medical Research Advocacy for their leadership and unwavering commitment to supporting policies that promote federal and private sector medical research and innovation. Reps. Wolf and Fattah have spearheaded efforts to create a legislative and regulatory climate conducive to medical innovation.
“Representatives Wolf and Fattah are exceptional champions for research,” said Research!America Chair John Edward Porter. “They have worked vigorously to increase funding for research, support policies that ignite public and private sector innovation, maintain our global competitiveness, and help patients and their families struggling with costly and debilitating diseases.”
Wolf is currently a senior member of the House Appropriations Committee, presides as chairman of the Commerce, Justice, Science Subcommittee, and is a member of the Transportation, Housing and Urban Development and State and Foreign Operations subcommittees. Throughout his distinguished tenure in Congress, Wolf has worked to advance the state of science and R&D, and he recognizes the role innovation plays in our nation’s economy, health and international competitiveness. Notably, he was a founder of the “Rising Above the Gathering Storm” Commission which sparked a national effort to bolster federal science, technology, engineering and mathematics (STEM) education and R&D programs. These efforts culminated in the enactment of the first America COMPETES Act in 2007 to increase public-private partnerships and provide assistance to innovators throughout the country. Wolf also supported the act’s reauthorization in 2010. He is an active member of several caucuses, including research and development, Parkinson’s, Alzheimer’s and multiple sclerosis. Continue reading →
Dear Research Advocate:
The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’t accounted for that way on the federal books. The arguments we’ve been making are now further bolstered by the BEA’s decision. Spread the word!
One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open letter published last week in Politico before the August recess. With more than half of the economic growth in the U.S. since WWII attributable to innovation — largely due to the nation’s commitment to higher education and federally supported research — our society and our economy are at risk if we continue on today’s trajectory.
These are arguments to use as we work to keep research and innovation in the conversation during the August recess. We have launched a reprise of our social media campaign using the hashtag #curesnotcuts. Please take part, so that policy makers, at home in their districts this month, get the message loud and clear that Americans want medical research to be protected from indiscriminate cuts; so they hear that research and innovation require committed, robust investment. Earlier this week, I was on “Radio Smart Talk” on WITF-FM, a Pennsylvania NPR affiliate. During that show I spoke about the damaging effect of the sequester and fielded questions from listeners. When making your case, you might find it useful to pull from those radio soundbites or from the points we contributed to an editorial that appeared in the The (Newark, NJ) Star-Ledger. Continue reading →
The following post is an excerpt from a recent op-ed by Harold L. Paz, MD, CEO of Penn State Milton S. Hershey Medical Center; senior vice president for health affairs, Penn State; and dean of the Penn State College of Medicine. You can read the full op-ed, published in several regional papers, here. The Penn State College of Medicine is a Research!America member.
Penn State Milton S. Hershey Medical Center is deeply concerned about the impact that sequestration will have on programs that are vital to the health of those we serve, including medical research supported by the National Institutes of Health (NIH).
As central Pennsylvania’s only academic health center we have a responsibility to serve our community by producing the next generation of health care professionals and biomedical scientists, discovering new medical knowledge that will improve health, and providing state-of-the-art care for serious or life-threatening conditions. Once sequestration takes effect on April 1, 2013, it will begin to take a toll on our efforts to fulfill those missions. Continue reading →